Akdital (AKT) Q1 2024 earnings summary

Executive summary

• Q1 2024 revenue reached MAD 611m, up 61% YoY, supported by new facilities and strong growth at established sites.

• Capacity rose to 2,425 beds following the February opening of the Khouribga International Clinic.

Financial highlights

• Revenue was MAD 611m in Q1 2024 versus MAD 380m in Q1 2023, a 61% increase.

• Admissions totaled 133,398, up from 83,988 in Q1 2023.

• Q1 investments were MAD 184m versus MAD 247m a year earlier, down 26%.

Outlook and guidance

• 12 new facilities are planned for 2024, including the Khouribga and Marrakech sites already operational; target capacity is over 3,700 beds.

• The 2024 capacity target is 1,400 additional beds and +61% versus 2,300 beds in 2023; further national expansion is planned beyond 2024.